Democritus University of Thrace (DUTH)
Μελέτη μοριακών δεικτών στον καρκίνο των ωοθηκών
Abstract
dc:descriptionOvarian cancer is one of the most common types of cancer and the leading cause of death due to gynecological malignancies. It is well established that dense CD8+ T-lymphocyte infiltration within the ovarian tumor masses correlates with favorable prognosis and improved patient survival. Still, the genes and the underlying molecular mechanisms that govern the recruitment and infiltration of T- lymphocytes in ovarian cancer remain quite vague. The aim of the present thesis was to identify genes involved in T-lymphocyte infiltration and to investigate their prognostic value and their role in the recruitment of lymphocytes in early stage ovarian cancer. In an attempt to pinpoint genes involved in CD8+ T-lymphocyte recruitment at the early stages of the disease, we focused in stage I and II ovarian tumors. To this end, a fluorescent Differential Display approach was utilized and 128 genes over-expressed in ovarian tumors with high numbers of CD8+ T-lymphocytes were identified. The expression of a significant number of genes was further evaluated with qPCR in a cohort of 38 early-stage ovarian cancer patients and a significant positive correlation of the mRNA levels of CXCL9, SMARCE1, MEIS1, GPC6, TMEM132D and JAG1 with the expression levels of CD8A, a marker of CD8+ T-lymphocyte infiltration, was documented. Importantly, forced over-expression of the chromatin remodeler SMARCE1 in SKOV3 ovarian cancer cells after transfection enhanced the expression of the chemokines IL8, RANTES and MIP1B and triggered the chemotaxis of CD8+ T-lymphocytes in vitro. Similarly, over-expression of the transcription factor MEIS1 in SKOV3 cells resulted in secretion of the chemokines IL8, GROα, RANTES, MIP1B, PARC and NAP2 and enhanced chemotaxis of CD8+ T-lymphocytes. Furthermore, MEIS1 was able to bind to the above chemokine promoters both in vitro and in vivo as found by Electrophoretic Mobility Shift Assays and Chromatin Immunoprecipitation. Finally, in order to evaluate the prognostic value of the genes identified with the fluorescent Differential Display, a retrospective clinical analysis of the survival of the early-stage ovarian cancer patients was performed. The expression of GPC6 and TMEM132D correlated with the overall survival of the patients and thus the two genes could serve as prognostic markers in early stage ovarian cancer. To sum up, in the present thesis several genes that could be used as markers of CD8+ T-lymphocyte infiltration and with prognostic value in early stage ovarian cancer were identified. Furthermore, two novel mechanisms regulating CD8+ T-lymphocyte recruitment at the tumor masses were demonstrated.
Degree
thesis:*- Grantor dc:publisher
- Democritus University of Thrace (DUTH)
- Year dc:date
- 2014
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Karapetsas, Athanasios
- Καραπέτσας, Αθανάσιος
Subjects
dc:subject × 38- Καρκίνος ωοθηκών αρχικού σταδίου
- Διήθηση CD8+ Τ-λεμφοκυττάρων
- Διαφορική έκθεση με φθορισμό
- Πρότυπο γονιδιακής έκφρασης
- Μοριακοί δείκτες
- Δείκτες διήθησης λεμφοκυττάρων
- Δείκτες πρόγνωσης
- Παράγοντας αναδιαμόρφωσης της χρωματίνης SMARCE1
- Μεταγραφικός παραγοντας MEIS1
- Γλυπικάνη 6 (GPC6)
- Διαμεμβρανική πρωτεΐνη 132D (TMEM132D)
- Χημειοκίνες
- Δοκιμή χημειοτακτισμού
- Ανοκατακρήμνιση χρωματίνης
- Ανάλυση επιβίωσης
- Early-stage ovarian cancer
- CD8+ T lymphocyte infiltration
- Fluorescent differential display
- Gene expression profiling
- Molecular markers
- Markers of lymphocyte infiltration
- Prognostic markers
- Chromatin remodeler SMARCE1
- Trancription factor MEIS1
- GPC6
- TMEM132D
- Chemokines
- Chemotaxis assay
- Chromatin immunoprecipitation (ChIP)
- Survival analysis
- Φυσικές Επιστήμες
- Βιολογία
- Ιατρική και Επιστήμες Υγείας
- Επιστήμες Υγείας
- Natural Sciences
- Biological Sciences
- Medical and Health Sciences
- Health Sciences
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/36871